Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP616103.RAdF03poycQpPP34b6jb1OLIRHtzqyDt7IfJoRJ2ttYlI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP616103.RAdF03poycQpPP34b6jb1OLIRHtzqyDt7IfJoRJ2ttYlI130_assertion type Assertion NP616103.RAdF03poycQpPP34b6jb1OLIRHtzqyDt7IfJoRJ2ttYlI130_head.
- NP616103.RAdF03poycQpPP34b6jb1OLIRHtzqyDt7IfJoRJ2ttYlI130_assertion wasGeneratedBy ECO_0000203 NP616103.RAdF03poycQpPP34b6jb1OLIRHtzqyDt7IfJoRJ2ttYlI130_provenance.
- NP616103.RAdF03poycQpPP34b6jb1OLIRHtzqyDt7IfJoRJ2ttYlI130_assertion wasDerivedFrom befree-2016 NP616103.RAdF03poycQpPP34b6jb1OLIRHtzqyDt7IfJoRJ2ttYlI130_provenance.
- NP616103.RAdF03poycQpPP34b6jb1OLIRHtzqyDt7IfJoRJ2ttYlI130_assertion SIO_000772 17581194 NP616103.RAdF03poycQpPP34b6jb1OLIRHtzqyDt7IfJoRJ2ttYlI130_provenance.
- NP616103.RAdF03poycQpPP34b6jb1OLIRHtzqyDt7IfJoRJ2ttYlI130_assertion evidence source_evidence_literature NP616103.RAdF03poycQpPP34b6jb1OLIRHtzqyDt7IfJoRJ2ttYlI130_provenance.
- NP616103.RAdF03poycQpPP34b6jb1OLIRHtzqyDt7IfJoRJ2ttYlI130_assertion description "[PAR-2 may therefore be involved in the pathophysiology of CRS and NP at different sites of activation, namely (i) proteases, (ii) the PAR-2 receptor itself or (iii) the application of novel agents that block NF-kappaB/IkappaB-alpha signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616103.RAdF03poycQpPP34b6jb1OLIRHtzqyDt7IfJoRJ2ttYlI130_provenance.